Patent Protection and High Drug Costs: The Pressure Is on

Article

Stories on drug manufacturers' patent-protection strategies suggest that the high costs of some drugs are receiving attention from other health care team members, as well as government officials.

In my last blog, I suggested that community pharmacists have a unique perspective on how high drug costs affect a patient, because they can put a face to the situation.

Now, stories on drug manufacturers’ patent-protection strategies in The Washington Post and HealthDay News suggest that the high costs of some drugs are receiving attention from other health care team members, as well as government officials.

I have always felt that the marketplace can take care of these types of problems, and I still think it is the best way. However, efforts like these are putting pressure on the marketplace to take action.

Will it take a court challenge, or will the manufacturers involved find a way to ensure everyone who needs their drug products can get access to them? Drug manufacturers have already done a lot to help patients who can’t afford a needed medication.

What do you think will happen?

Related Videos
cropped view of man performing chest compression on dummy during cpr training class - Image credit: LIGHTFIELD STUDIOS | stock.adobe.com
Medicine law concept. Judges gavel with pills | Image Credit: Iren Moroz - stock.adobe.com
Image credit: New Africa | stock.adobe.com
biosimilar word or concept represented by wooden letter tiles on a wooden table with glasses and a book | Image Credit: lexiconimages - stock.adobe.com
Image credit: alicja neumiler | stock.adobe.com
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Image Credit: Pixel-Shot | stock.adobe.com
Pharmacist holding medicine box and capsule pack in pharmacy drugstore. -- Image credit: I Viewfinder | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.